nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—CYP2C9—Leflunomide—systemic scleroderma	0.0659	0.316	CbGbCtD
Voriconazole—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0607	0.291	CbGbCtD
Voriconazole—CYP2C19—Prednisone—systemic scleroderma	0.0391	0.188	CbGbCtD
Voriconazole—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0237	0.114	CbGbCtD
Voriconazole—CYP2C9—cardial valve—systemic scleroderma	0.0209	0.403	CbGeAlD
Voriconazole—CYP3A4—Prednisone—systemic scleroderma	0.0189	0.0908	CbGbCtD
Voriconazole—FMO1—digestive system—systemic scleroderma	0.00305	0.0588	CbGeAlD
Voriconazole—FMO1—tendon—systemic scleroderma	0.0029	0.056	CbGeAlD
Voriconazole—PTGS1—artery—systemic scleroderma	0.00286	0.0551	CbGeAlD
Voriconazole—FMO1—lung—systemic scleroderma	0.00255	0.0491	CbGeAlD
Voriconazole—PTGS1—endothelium—systemic scleroderma	0.00241	0.0466	CbGeAlD
Voriconazole—PTGS1—blood vessel—systemic scleroderma	0.00223	0.043	CbGeAlD
Voriconazole—FMO3—lung—systemic scleroderma	0.0022	0.0425	CbGeAlD
Voriconazole—CYP2C19—digestive system—systemic scleroderma	0.00116	0.0225	CbGeAlD
Voriconazole—PTGS1—connective tissue—systemic scleroderma	0.00114	0.022	CbGeAlD
Voriconazole—CYP2B6—skin of body—systemic scleroderma	0.00114	0.022	CbGeAlD
Voriconazole—PTGS1—smooth muscle tissue—systemic scleroderma	0.00104	0.0201	CbGeAlD
Voriconazole—PTGS1—skin of body—systemic scleroderma	0.00103	0.0199	CbGeAlD
Voriconazole—CYP3A5—digestive system—systemic scleroderma	0.000918	0.0177	CbGeAlD
Voriconazole—CYP2B6—digestive system—systemic scleroderma	0.000912	0.0176	CbGeAlD
Voriconazole—CYP2C9—digestive system—systemic scleroderma	0.000903	0.0174	CbGeAlD
Voriconazole—PTGS1—digestive system—systemic scleroderma	0.000824	0.0159	CbGeAlD
Voriconazole—PTGS1—tendon—systemic scleroderma	0.000785	0.0151	CbGeAlD
Voriconazole—CYP3A5—lung—systemic scleroderma	0.000766	0.0148	CbGeAlD
Voriconazole—CYP2B6—lung—systemic scleroderma	0.000762	0.0147	CbGeAlD
Voriconazole—CYP3A4—digestive system—systemic scleroderma	0.000689	0.0133	CbGeAlD
Voriconazole—PTGS1—lung—systemic scleroderma	0.000689	0.0133	CbGeAlD
Voriconazole—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000226	0.000305	CcSEcCtD
Voriconazole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000225	0.000304	CcSEcCtD
Voriconazole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000304	CcSEcCtD
Voriconazole—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000304	CcSEcCtD
Voriconazole—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000304	CcSEcCtD
Voriconazole—Myocardial infarction—Prednisone—systemic scleroderma	0.000224	0.000303	CcSEcCtD
Voriconazole—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000224	0.000303	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000224	0.000303	CcSEcCtD
Voriconazole—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000303	CcSEcCtD
Voriconazole—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000223	0.000302	CcSEcCtD
Voriconazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.000223	0.000302	CcSEcCtD
Voriconazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000223	0.000302	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000302	CcSEcCtD
Voriconazole—Insomnia—Lisinopril—systemic scleroderma	0.000222	0.0003	CcSEcCtD
Voriconazole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000222	0.0003	CcSEcCtD
Voriconazole—Paraesthesia—Lisinopril—systemic scleroderma	0.000221	0.000298	CcSEcCtD
Voriconazole—Vomiting—Captopril—systemic scleroderma	0.000221	0.000298	CcSEcCtD
Voriconazole—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000297	CcSEcCtD
Voriconazole—Dyspnoea—Lisinopril—systemic scleroderma	0.000219	0.000296	CcSEcCtD
Voriconazole—Rash—Captopril—systemic scleroderma	0.000219	0.000296	CcSEcCtD
Voriconazole—Dermatitis—Captopril—systemic scleroderma	0.000219	0.000295	CcSEcCtD
Voriconazole—Somnolence—Lisinopril—systemic scleroderma	0.000218	0.000295	CcSEcCtD
Voriconazole—Headache—Captopril—systemic scleroderma	0.000217	0.000294	CcSEcCtD
Voriconazole—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000293	CcSEcCtD
Voriconazole—Dyspepsia—Lisinopril—systemic scleroderma	0.000216	0.000292	CcSEcCtD
Voriconazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000216	0.000292	CcSEcCtD
Voriconazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000216	0.000292	CcSEcCtD
Voriconazole—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000291	CcSEcCtD
Voriconazole—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000291	CcSEcCtD
Voriconazole—Infection—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000289	CcSEcCtD
Voriconazole—Decreased appetite—Lisinopril—systemic scleroderma	0.000214	0.000289	CcSEcCtD
Voriconazole—Eosinophilia—Methotrexate—systemic scleroderma	0.000212	0.000287	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000212	0.000287	CcSEcCtD
Voriconazole—Shock—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000286	CcSEcCtD
Voriconazole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000285	CcSEcCtD
Voriconazole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000285	CcSEcCtD
Voriconazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.000211	0.000285	CcSEcCtD
Voriconazole—Pancreatitis—Methotrexate—systemic scleroderma	0.00021	0.000284	CcSEcCtD
Voriconazole—Constipation—Lisinopril—systemic scleroderma	0.00021	0.000284	CcSEcCtD
Voriconazole—Pain—Lisinopril—systemic scleroderma	0.00021	0.000284	CcSEcCtD
Voriconazole—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000284	CcSEcCtD
Voriconazole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000283	CcSEcCtD
Voriconazole—Bradycardia—Prednisone—systemic scleroderma	0.000209	0.000283	CcSEcCtD
Voriconazole—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000281	CcSEcCtD
Voriconazole—Diarrhoea—Azathioprine—systemic scleroderma	0.000207	0.00028	CcSEcCtD
Voriconazole—Nausea—Captopril—systemic scleroderma	0.000206	0.000279	CcSEcCtD
Voriconazole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000277	CcSEcCtD
Voriconazole—Asthenia—Leflunomide—systemic scleroderma	0.000205	0.000277	CcSEcCtD
Voriconazole—Hallucination—Prednisone—systemic scleroderma	0.000204	0.000276	CcSEcCtD
Voriconazole—Pancytopenia—Methotrexate—systemic scleroderma	0.000204	0.000275	CcSEcCtD
Voriconazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.000203	0.000274	CcSEcCtD
Voriconazole—Pruritus—Leflunomide—systemic scleroderma	0.000202	0.000273	CcSEcCtD
Voriconazole—Connective tissue disorder—Prednisone—systemic scleroderma	0.000202	0.000273	CcSEcCtD
Voriconazole—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000272	CcSEcCtD
Voriconazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000201	0.000272	CcSEcCtD
Voriconazole—Dysuria—Methotrexate—systemic scleroderma	0.000201	0.000271	CcSEcCtD
Voriconazole—Dizziness—Azathioprine—systemic scleroderma	0.0002	0.000271	CcSEcCtD
Voriconazole—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000198	0.000267	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000265	CcSEcCtD
Voriconazole—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000196	0.000265	CcSEcCtD
Voriconazole—Asthenia—Mycophenolic acid—systemic scleroderma	0.000196	0.000265	CcSEcCtD
Voriconazole—Diarrhoea—Leflunomide—systemic scleroderma	0.000196	0.000264	CcSEcCtD
Voriconazole—Urticaria—Lisinopril—systemic scleroderma	0.000195	0.000264	CcSEcCtD
Voriconazole—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000263	CcSEcCtD
Voriconazole—Body temperature increased—Lisinopril—systemic scleroderma	0.000194	0.000263	CcSEcCtD
Voriconazole—Abdominal pain—Lisinopril—systemic scleroderma	0.000194	0.000263	CcSEcCtD
Voriconazole—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000261	CcSEcCtD
Voriconazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000193	0.000261	CcSEcCtD
Voriconazole—Vomiting—Azathioprine—systemic scleroderma	0.000193	0.00026	CcSEcCtD
Voriconazole—Pneumonia—Methotrexate—systemic scleroderma	0.000192	0.00026	CcSEcCtD
Voriconazole—Eye disorder—Prednisone—systemic scleroderma	0.000192	0.000259	CcSEcCtD
Voriconazole—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000259	CcSEcCtD
Voriconazole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000259	CcSEcCtD
Voriconazole—Infestation—Methotrexate—systemic scleroderma	0.000191	0.000259	CcSEcCtD
Voriconazole—Infestation NOS—Methotrexate—systemic scleroderma	0.000191	0.000259	CcSEcCtD
Voriconazole—Rash—Azathioprine—systemic scleroderma	0.000191	0.000258	CcSEcCtD
Voriconazole—Dermatitis—Azathioprine—systemic scleroderma	0.000191	0.000258	CcSEcCtD
Voriconazole—Depression—Methotrexate—systemic scleroderma	0.000191	0.000258	CcSEcCtD
Voriconazole—Flushing—Prednisone—systemic scleroderma	0.000191	0.000258	CcSEcCtD
Voriconazole—Headache—Azathioprine—systemic scleroderma	0.00019	0.000256	CcSEcCtD
Voriconazole—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00019	0.000256	CcSEcCtD
Voriconazole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000256	CcSEcCtD
Voriconazole—Dizziness—Leflunomide—systemic scleroderma	0.000189	0.000256	CcSEcCtD
Voriconazole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000253	CcSEcCtD
Voriconazole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000187	0.000252	CcSEcCtD
Voriconazole—Stomatitis—Methotrexate—systemic scleroderma	0.000186	0.000252	CcSEcCtD
Voriconazole—Angiopathy—Prednisone—systemic scleroderma	0.000186	0.000252	CcSEcCtD
Voriconazole—Conjunctivitis—Methotrexate—systemic scleroderma	0.000186	0.000251	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000251	CcSEcCtD
Voriconazole—Immune system disorder—Prednisone—systemic scleroderma	0.000186	0.000251	CcSEcCtD
Voriconazole—Pain—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000249	CcSEcCtD
Voriconazole—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000249	CcSEcCtD
Voriconazole—Arrhythmia—Prednisone—systemic scleroderma	0.000184	0.000248	CcSEcCtD
Voriconazole—Sweating—Methotrexate—systemic scleroderma	0.000183	0.000248	CcSEcCtD
Voriconazole—Haematuria—Methotrexate—systemic scleroderma	0.000182	0.000246	CcSEcCtD
Voriconazole—Vomiting—Leflunomide—systemic scleroderma	0.000182	0.000246	CcSEcCtD
Voriconazole—Alopecia—Prednisone—systemic scleroderma	0.000182	0.000245	CcSEcCtD
Voriconazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.000181	0.000245	CcSEcCtD
Voriconazole—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000181	0.000244	CcSEcCtD
Voriconazole—Dizziness—Mycophenolic acid—systemic scleroderma	0.00018	0.000244	CcSEcCtD
Voriconazole—Epistaxis—Methotrexate—systemic scleroderma	0.00018	0.000244	CcSEcCtD
Voriconazole—Rash—Leflunomide—systemic scleroderma	0.00018	0.000244	CcSEcCtD
Voriconazole—Dermatitis—Leflunomide—systemic scleroderma	0.00018	0.000244	CcSEcCtD
Voriconazole—Mental disorder—Prednisone—systemic scleroderma	0.00018	0.000243	CcSEcCtD
Voriconazole—Nausea—Azathioprine—systemic scleroderma	0.00018	0.000243	CcSEcCtD
Voriconazole—Headache—Leflunomide—systemic scleroderma	0.000179	0.000242	CcSEcCtD
Voriconazole—Erythema—Prednisone—systemic scleroderma	0.000179	0.000242	CcSEcCtD
Voriconazole—Malnutrition—Prednisone—systemic scleroderma	0.000179	0.000242	CcSEcCtD
Voriconazole—Agranulocytosis—Methotrexate—systemic scleroderma	0.000178	0.000241	CcSEcCtD
Voriconazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000177	0.00024	CcSEcCtD
Voriconazole—Asthenia—Lisinopril—systemic scleroderma	0.000176	0.000238	CcSEcCtD
Voriconazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000238	CcSEcCtD
Voriconazole—Pruritus—Lisinopril—systemic scleroderma	0.000174	0.000235	CcSEcCtD
Voriconazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000173	0.000234	CcSEcCtD
Voriconazole—Rash—Mycophenolic acid—systemic scleroderma	0.000172	0.000233	CcSEcCtD
Voriconazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000172	0.000232	CcSEcCtD
Voriconazole—Hepatitis—Methotrexate—systemic scleroderma	0.000172	0.000232	CcSEcCtD
Voriconazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000231	CcSEcCtD
Voriconazole—Headache—Mycophenolic acid—systemic scleroderma	0.000171	0.000231	CcSEcCtD
Voriconazole—Pharyngitis—Methotrexate—systemic scleroderma	0.00017	0.00023	CcSEcCtD
Voriconazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00023	CcSEcCtD
Voriconazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00023	CcSEcCtD
Voriconazole—Nausea—Leflunomide—systemic scleroderma	0.00017	0.00023	CcSEcCtD
Voriconazole—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00017	0.000229	CcSEcCtD
Voriconazole—Vision blurred—Prednisone—systemic scleroderma	0.000169	0.000228	CcSEcCtD
Voriconazole—Urethral disorder—Methotrexate—systemic scleroderma	0.000168	0.000227	CcSEcCtD
Voriconazole—Diarrhoea—Lisinopril—systemic scleroderma	0.000168	0.000227	CcSEcCtD
Voriconazole—Ill-defined disorder—Prednisone—systemic scleroderma	0.000166	0.000224	CcSEcCtD
Voriconazole—Visual impairment—Methotrexate—systemic scleroderma	0.000165	0.000224	CcSEcCtD
Voriconazole—Anaemia—Prednisone—systemic scleroderma	0.000165	0.000223	CcSEcCtD
Voriconazole—Agitation—Prednisone—systemic scleroderma	0.000164	0.000222	CcSEcCtD
Voriconazole—Angioedema—Prednisone—systemic scleroderma	0.000163	0.000221	CcSEcCtD
Voriconazole—Dizziness—Lisinopril—systemic scleroderma	0.000163	0.00022	CcSEcCtD
Voriconazole—Erythema multiforme—Methotrexate—systemic scleroderma	0.000162	0.000219	CcSEcCtD
Voriconazole—Nausea—Mycophenolic acid—systemic scleroderma	0.000162	0.000219	CcSEcCtD
Voriconazole—Malaise—Prednisone—systemic scleroderma	0.000161	0.000218	CcSEcCtD
Voriconazole—Vertigo—Prednisone—systemic scleroderma	0.000161	0.000217	CcSEcCtD
Voriconazole—Eye disorder—Methotrexate—systemic scleroderma	0.00016	0.000217	CcSEcCtD
Voriconazole—Syncope—Prednisone—systemic scleroderma	0.00016	0.000217	CcSEcCtD
Voriconazole—Tinnitus—Methotrexate—systemic scleroderma	0.00016	0.000216	CcSEcCtD
Voriconazole—Cardiac disorder—Methotrexate—systemic scleroderma	0.000159	0.000215	CcSEcCtD
Voriconazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000214	CcSEcCtD
Voriconazole—Loss of consciousness—Prednisone—systemic scleroderma	0.000157	0.000212	CcSEcCtD
Voriconazole—Vomiting—Lisinopril—systemic scleroderma	0.000156	0.000211	CcSEcCtD
Voriconazole—Angiopathy—Methotrexate—systemic scleroderma	0.000156	0.000211	CcSEcCtD
Voriconazole—Immune system disorder—Methotrexate—systemic scleroderma	0.000155	0.00021	CcSEcCtD
Voriconazole—Rash—Lisinopril—systemic scleroderma	0.000155	0.000209	CcSEcCtD
Voriconazole—Convulsion—Prednisone—systemic scleroderma	0.000155	0.000209	CcSEcCtD
Voriconazole—Dermatitis—Lisinopril—systemic scleroderma	0.000155	0.000209	CcSEcCtD
Voriconazole—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000155	0.000209	CcSEcCtD
Voriconazole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000209	CcSEcCtD
Voriconazole—Hypertension—Prednisone—systemic scleroderma	0.000154	0.000209	CcSEcCtD
Voriconazole—Chills—Methotrexate—systemic scleroderma	0.000154	0.000208	CcSEcCtD
Voriconazole—Headache—Lisinopril—systemic scleroderma	0.000154	0.000208	CcSEcCtD
Voriconazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000206	CcSEcCtD
Voriconazole—Arthralgia—Prednisone—systemic scleroderma	0.000152	0.000206	CcSEcCtD
Voriconazole—Myalgia—Prednisone—systemic scleroderma	0.000152	0.000206	CcSEcCtD
Voriconazole—Anxiety—Prednisone—systemic scleroderma	0.000152	0.000205	CcSEcCtD
Voriconazole—Alopecia—Methotrexate—systemic scleroderma	0.000152	0.000205	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000151	0.000204	CcSEcCtD
Voriconazole—Discomfort—Prednisone—systemic scleroderma	0.00015	0.000203	CcSEcCtD
Voriconazole—Mental disorder—Methotrexate—systemic scleroderma	0.00015	0.000203	CcSEcCtD
Voriconazole—Malnutrition—Methotrexate—systemic scleroderma	0.000149	0.000202	CcSEcCtD
Voriconazole—Erythema—Methotrexate—systemic scleroderma	0.000149	0.000202	CcSEcCtD
Voriconazole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000199	CcSEcCtD
Voriconazole—Dysgeusia—Methotrexate—systemic scleroderma	0.000146	0.000198	CcSEcCtD
Voriconazole—Nausea—Lisinopril—systemic scleroderma	0.000146	0.000197	CcSEcCtD
Voriconazole—Anaphylactic shock—Prednisone—systemic scleroderma	0.000146	0.000197	CcSEcCtD
Voriconazole—Oedema—Prednisone—systemic scleroderma	0.000146	0.000197	CcSEcCtD
Voriconazole—Infection—Prednisone—systemic scleroderma	0.000145	0.000196	CcSEcCtD
Voriconazole—Back pain—Methotrexate—systemic scleroderma	0.000145	0.000195	CcSEcCtD
Voriconazole—Shock—Prednisone—systemic scleroderma	0.000144	0.000194	CcSEcCtD
Voriconazole—Nervous system disorder—Prednisone—systemic scleroderma	0.000143	0.000193	CcSEcCtD
Voriconazole—Tachycardia—Prednisone—systemic scleroderma	0.000142	0.000193	CcSEcCtD
Voriconazole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000192	CcSEcCtD
Voriconazole—Skin disorder—Prednisone—systemic scleroderma	0.000142	0.000192	CcSEcCtD
Voriconazole—Hyperhidrosis—Prednisone—systemic scleroderma	0.000141	0.000191	CcSEcCtD
Voriconazole—Vision blurred—Methotrexate—systemic scleroderma	0.000141	0.00019	CcSEcCtD
Voriconazole—Anorexia—Prednisone—systemic scleroderma	0.000139	0.000188	CcSEcCtD
Voriconazole—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000139	0.000187	CcSEcCtD
Voriconazole—Anaemia—Methotrexate—systemic scleroderma	0.000138	0.000187	CcSEcCtD
Voriconazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000185	CcSEcCtD
Voriconazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000184	CcSEcCtD
Voriconazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000183	CcSEcCtD
Voriconazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000182	CcSEcCtD
Voriconazole—Malaise—Methotrexate—systemic scleroderma	0.000135	0.000182	CcSEcCtD
Voriconazole—Vertigo—Methotrexate—systemic scleroderma	0.000134	0.000181	CcSEcCtD
Voriconazole—Leukopenia—Methotrexate—systemic scleroderma	0.000134	0.000181	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000133	0.00018	CcSEcCtD
Voriconazole—Insomnia—Prednisone—systemic scleroderma	0.000132	0.000178	CcSEcCtD
Voriconazole—Paraesthesia—Prednisone—systemic scleroderma	0.000131	0.000177	CcSEcCtD
Voriconazole—Cough—Methotrexate—systemic scleroderma	0.00013	0.000176	CcSEcCtD
Voriconazole—Convulsion—Methotrexate—systemic scleroderma	0.000129	0.000175	CcSEcCtD
Voriconazole—Dyspepsia—Prednisone—systemic scleroderma	0.000128	0.000174	CcSEcCtD
Voriconazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000173	CcSEcCtD
Voriconazole—Arthralgia—Methotrexate—systemic scleroderma	0.000127	0.000172	CcSEcCtD
Voriconazole—Myalgia—Methotrexate—systemic scleroderma	0.000127	0.000172	CcSEcCtD
Voriconazole—Chest pain—Methotrexate—systemic scleroderma	0.000127	0.000172	CcSEcCtD
Voriconazole—Decreased appetite—Prednisone—systemic scleroderma	0.000127	0.000171	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000126	0.000171	CcSEcCtD
Voriconazole—Discomfort—Methotrexate—systemic scleroderma	0.000126	0.00017	CcSEcCtD
Voriconazole—Constipation—Prednisone—systemic scleroderma	0.000125	0.000169	CcSEcCtD
Voriconazole—Confusional state—Methotrexate—systemic scleroderma	0.000123	0.000166	CcSEcCtD
Voriconazole—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000122	0.000165	CcSEcCtD
Voriconazole—Infection—Methotrexate—systemic scleroderma	0.000121	0.000164	CcSEcCtD
Voriconazole—Feeling abnormal—Prednisone—systemic scleroderma	0.00012	0.000163	CcSEcCtD
Voriconazole—Nervous system disorder—Methotrexate—systemic scleroderma	0.00012	0.000162	CcSEcCtD
Voriconazole—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000119	0.000161	CcSEcCtD
Voriconazole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000119	0.000161	CcSEcCtD
Voriconazole—Skin disorder—Methotrexate—systemic scleroderma	0.000118	0.00016	CcSEcCtD
Voriconazole—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000118	0.000159	CcSEcCtD
Voriconazole—Anorexia—Methotrexate—systemic scleroderma	0.000116	0.000157	CcSEcCtD
Voriconazole—Urticaria—Prednisone—systemic scleroderma	0.000116	0.000157	CcSEcCtD
Voriconazole—Body temperature increased—Prednisone—systemic scleroderma	0.000115	0.000156	CcSEcCtD
Voriconazole—Abdominal pain—Prednisone—systemic scleroderma	0.000115	0.000156	CcSEcCtD
Voriconazole—Hypotension—Methotrexate—systemic scleroderma	0.000114	0.000154	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000111	0.00015	CcSEcCtD
Voriconazole—Insomnia—Methotrexate—systemic scleroderma	0.00011	0.000149	CcSEcCtD
Voriconazole—Paraesthesia—Methotrexate—systemic scleroderma	0.00011	0.000148	CcSEcCtD
Voriconazole—Dyspnoea—Methotrexate—systemic scleroderma	0.000109	0.000147	CcSEcCtD
Voriconazole—Somnolence—Methotrexate—systemic scleroderma	0.000108	0.000147	CcSEcCtD
Voriconazole—Hypersensitivity—Prednisone—systemic scleroderma	0.000108	0.000145	CcSEcCtD
Voriconazole—Dyspepsia—Methotrexate—systemic scleroderma	0.000107	0.000145	CcSEcCtD
Voriconazole—Decreased appetite—Methotrexate—systemic scleroderma	0.000106	0.000143	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000105	0.000142	CcSEcCtD
Voriconazole—Asthenia—Prednisone—systemic scleroderma	0.000105	0.000142	CcSEcCtD
Voriconazole—Pain—Methotrexate—systemic scleroderma	0.000104	0.000141	CcSEcCtD
Voriconazole—Pruritus—Prednisone—systemic scleroderma	0.000103	0.00014	CcSEcCtD
Voriconazole—Feeling abnormal—Methotrexate—systemic scleroderma	0.000101	0.000136	CcSEcCtD
Voriconazole—Diarrhoea—Prednisone—systemic scleroderma	9.99e-05	0.000135	CcSEcCtD
Voriconazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	9.97e-05	0.000135	CcSEcCtD
Voriconazole—Urticaria—Methotrexate—systemic scleroderma	9.69e-05	0.000131	CcSEcCtD
Voriconazole—Dizziness—Prednisone—systemic scleroderma	9.65e-05	0.00013	CcSEcCtD
Voriconazole—Abdominal pain—Methotrexate—systemic scleroderma	9.64e-05	0.00013	CcSEcCtD
Voriconazole—Body temperature increased—Methotrexate—systemic scleroderma	9.64e-05	0.00013	CcSEcCtD
Voriconazole—Vomiting—Prednisone—systemic scleroderma	9.28e-05	0.000125	CcSEcCtD
Voriconazole—Rash—Prednisone—systemic scleroderma	9.2e-05	0.000124	CcSEcCtD
Voriconazole—Dermatitis—Prednisone—systemic scleroderma	9.19e-05	0.000124	CcSEcCtD
Voriconazole—Headache—Prednisone—systemic scleroderma	9.14e-05	0.000124	CcSEcCtD
Voriconazole—Hypersensitivity—Methotrexate—systemic scleroderma	8.99e-05	0.000121	CcSEcCtD
Voriconazole—Asthenia—Methotrexate—systemic scleroderma	8.75e-05	0.000118	CcSEcCtD
Voriconazole—Nausea—Prednisone—systemic scleroderma	8.67e-05	0.000117	CcSEcCtD
Voriconazole—Pruritus—Methotrexate—systemic scleroderma	8.63e-05	0.000117	CcSEcCtD
Voriconazole—Diarrhoea—Methotrexate—systemic scleroderma	8.35e-05	0.000113	CcSEcCtD
Voriconazole—Dizziness—Methotrexate—systemic scleroderma	8.07e-05	0.000109	CcSEcCtD
Voriconazole—Vomiting—Methotrexate—systemic scleroderma	7.76e-05	0.000105	CcSEcCtD
Voriconazole—Rash—Methotrexate—systemic scleroderma	7.69e-05	0.000104	CcSEcCtD
Voriconazole—Dermatitis—Methotrexate—systemic scleroderma	7.68e-05	0.000104	CcSEcCtD
Voriconazole—Headache—Methotrexate—systemic scleroderma	7.64e-05	0.000103	CcSEcCtD
Voriconazole—Nausea—Methotrexate—systemic scleroderma	7.25e-05	9.79e-05	CcSEcCtD
